Daniel C. Rowe

• Represented CommScope Holding Company Inc. in its $7.4 billion acquisition of ARRIS International plc.
• Represented Pamlico Capital in its sale of and reinvestment in Clarity Telecom d/b/a Vast, a broadband communications platform focused on providing Internet, cable television, and telephone services.
• Represented Ridgemont Equity Partners in its acquisition of Munch’s Supply, a leading wholesale distributor of heating, ventilation, and air conditioning (HVAC) equipment.
• Represented Pamlico Capital in its investment in a management service organization formed to support JAG-ONE Physical Therapy’s 38 outpatient clinics across New York and New Jersey.
• Represented Ridgemont Equity Partners in its acquisition of a nationwide fleet maintenance and repair services provider.
• Represented a franchisee in its sale of six Krispy Kreme franchise locations to Krispy Kreme Doughnut Corporation.
• Represented private equity firm Pamlico Capital and its portfolio company Clarity Telecom in the acquisition of NTS Communications.
• Represented private equity firm Pamlico Capital and its portfolio company Securadyne Systems, a company specializing in integrated security solutions through offerings of security consulting, design, engineering, and installation, in the sale of Securadyne Systems to Allied Universal, a leading security guard and facility services company.
• Advised a publicly traded supplier of water and water dispensers in an agreement to acquire by merger a publicly traded competitor for more than $260 million in cash and stock.
• Represented a venture-capital-funded genome-editing company in a worldwide partnership, worth up to $1.6 billion.
• Counseled an NYSE-listed energy company in a strategic alliance with an on-site power generation systems company to integrate an energy platform with smart storage solutions, including an initial 50-megawatt project involving distributed generation systems at more than 150 sites.

• Represented an international health care group and U.S. subsidiary in obtaining multinational license rights to three cardiovascular drugs from a public pharmaceutical company for more than $260 million in cash and up to $480 million in milestone and royalty payments.
• Advised an international drug development services organization in the acquisitions of multiple pharmaceutical contract development and manufacturing organizations.
• Represented a global solid-state LED lighting and semiconductor manufacturing company in a Hong Kong joint venture to sell mid-power lighting class LED packaged products.
• Advised public companies in various industries on public disclosure and securities law compliance matters, listing requirements, corporate governance, and general corporate matters.
• Counseled public and private clients on technology contracting, licensing, and other commercial transactions.

Dan Rowe is a senior associate in Alston & Bird’s Corporate & Business Transactions Group. He advises public and private clients, including private equity investment firms and their portfolio companies, on mergers, acquisitions, divestitures, joint ventures, and general corporate matters.

Dan is recognized in The Best Lawyers in America^© “Ones to Watch” in the Corporate, Leveraged Buyouts and Private Equity, and Mergers & Acquisitions Law categories for 2021 and 2022.

Dan received his J.D. from Duke University and his B.A., summa cum laude, from North Carolina State University, where he was elected to Phi Beta Kappa. During law school, Dan also served as a judicial intern with the Supreme Court of North Carolina.

Bar Admissions

• North Carolina

Education

• Duke University (J.D., 2015)
• North Carolina State University (B.A., 2012)